P201: Neoadjuvant HER2-Targeted Therapy Response by BluePrint Gene Expression-Based Molecular Subtyping in patients with HER2+ Early-Stage Breast Cancer from FLEX
Year: 2025
Type: conference-abstract
Source: The Breast
Authors: L. Samiian, A. Brufsky, S. Ugyan, I. Kapoor, V. Poillucci, J. O'Shaughnessy, W Audeh
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,200
OpenAlex ID: W4408276758